Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Influenza A Virus, H1N1 Subtype"" wg kryterium: Temat


Tytuł:
Submerged leaves of live indoor foliage plants adsorb H1N1 influenza virus from suspension.
Autorzy:
Song HJ; Department of Biological Engineering, Konkuk University, Korea, South Korea.
Yang SW; Department of Biological Engineering, Konkuk University, Korea, South Korea.
Jo JW; Department of Biological Engineering, Konkuk University, Korea, South Korea.
Choi YK; Department of Biological Engineering, Konkuk University, Korea, South Korea.
Lee IS; Department of Biological Sciences, Konkuk University, Korea, South Korea.
Lee BU; Department of Mechanical and Aerospace Engineering, Konkuk University, Korea, South Korea.
Lee SH; Department of Biological Engineering, Konkuk University, Korea, South Korea.
Kim HH; Department of Nano-chemical, Biological and Environmental Engineering, Seokyeong University, Seoul, South Korea.
Kim KJ; Urban Agriculture Research Division, National Institute of Horticultural and Herbal Science, Chungjoo, Korea.
Kim HJ; Department of Biological Engineering, Konkuk University, Korea, South Korea.
Pokaż więcej
Źródło:
Plant signaling & behavior [Plant Signal Behav] 2023 Dec 31; Vol. 18 (1), pp. 2163869.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Papillomavirus Infections*
Humans ; Plants ; Plant Leaves ; Water
Czasopismo naukowe
Tytuł:
End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal.
Autorzy:
Kislaya I; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Torres AR; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Gomes L; Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Melo A; Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Machado A; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Henriques C; Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Verdasca N; Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Guiomar R; Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Rodrigues AP; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge IP (INSA, IP), Lisboa, Portugal.
Surveillance Network NI
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 15; Vol. 19 (3), pp. 2263219. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*
Humans ; Adolescent ; Seasons ; Influenza A Virus, H3N2 Subtype ; Portugal/epidemiology ; Case-Control Studies ; Sentinel Surveillance ; Vaccination ; Vaccines, Combined ; Primary Health Care
Czasopismo naukowe
Tytuł:
Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors.
Autorzy:
Liu C; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China; Suzhou Research Institute of Shandong University, Room607, Building B of NUSP, NO.388 Ruoshui Road, SIP, Suzhou, Jiangsu, 215123, PR China.
Zhang Y; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China.
Li P; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China; Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Jia H; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China.
Ju H; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China.
Zhang J; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China.
Ferreira da Silva-Júnior E; Research Group of Biological and Molecular Chemistry, Institute of Chemistry and Biotechnology, Federal University of Alagoas, Lourival Melo Mota Avenue, AC. Simões Campus, 57072-970, Alagoas, Maceió, Brazil.
Samanta S; Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Khandwa Road, Indore, 453552, Madhya Pradesh, India.
Kar P; Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Khandwa Road, Indore, 453552, Madhya Pradesh, India. Electronic address: .
Huang B; China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, 44 West Culture Road, 250012, Jinan, Shandong, PR China. Electronic address: .
Liu X; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China. Electronic address: .
Zhan P; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China. Electronic address: .
Pokaż więcej
Źródło:
European journal of medicinal chemistry [Eur J Med Chem] 2023 Dec 05; Vol. 261, pp. 115845. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/drug therapy
Chalcones*/pharmacology
Influenza A Virus, H1N1 Subtype*
Humans ; Oseltamivir/pharmacology ; Antiviral Agents/chemistry ; Active Transport, Cell Nucleus
Czasopismo naukowe
Tytuł:
A novel N -heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation.
Autorzy:
Zhang J; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Liu C; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.; Suzhou Research Institute of Shandong University, Suzhou, Jiangsu, P.R. China.
Jia R; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Zhang X; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Zhang J; Institute of Medical Sciences, The Second Hospital, Shandong University, Jinan, Shandong, P.R. China.
Bertagnin C; Department of Molecular Medicine, University of Padova, Padova, Italy.
Bonomini A; Department of Molecular Medicine, University of Padova, Padova, Italy.
Guizzo L; Department of Molecular Medicine, University of Padova, Padova, Italy.
Jiang Y; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Jia H; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Jia S; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.
Ma X; Institute of Poultry Science, Shandong Academy of Agricultural Sciences, Jinan, Shandong, P.R. China.
Loregian A; Department of Molecular Medicine, University of Padova, Padova, Italy.
Huang B; Institute of Poultry Science, Shandong Academy of Agricultural Sciences, Jinan, Shandong, P.R. China.
Zhan P; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.; China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Jinan, Shandong, PR China.
Liu X; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R. China.; China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Jinan, Shandong, PR China.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 2277135. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H5N1 Subtype*/metabolism
Influenza A Virus, H1N1 Subtype*
Oseltamivir/pharmacology ; Oseltamivir/chemistry ; Neuraminidase ; Molecular Docking Simulation ; Influenza A Virus, H3N2 Subtype/metabolism ; Glycoside Hydrolases
Czasopismo naukowe
Tytuł:
PLK3 facilitates replication of swine influenza virus by phosphorylating viral NP protein.
Autorzy:
Ren C; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Chen T; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Zhang S; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Gao Q; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Zou J; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Li P; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Wang B; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Zhao Y; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
OuYang A; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Suolang S; Department of Animal Science, Tibet Agricultural and Animal Husbandry College, Linzhi, People's Republic of China.
Zhou H; National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.; Frontiers Science Center for Animal Breeding and Sustainable Production, Wuhan, People's Republic of China.; Hubei Hongshan Laboratory, Wuhan, People's Republic of China.; Key Laboratory of Preventive Veterinary Medicine in Hubei Province, the Cooperative Innovation Center for Sustainable Pig Production, Wuhan, People's Republic of China.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (2), pp. 2275606. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H1N1 Subtype*/genetics
Influenza A virus*/physiology
Influenza, Human*
Orthomyxoviridae Infections*
Swine Diseases*
Animals ; Swine ; Humans ; Viral Proteins/genetics ; Nucleoproteins/metabolism ; Protein Serine-Threonine Kinases/genetics ; Serine ; Virus Replication/genetics ; Tumor Suppressor Proteins
Czasopismo naukowe
Tytuł:
Utility of glutaraldehyde-fixed turkey red blood cells for influenza virus detection after 18 months of storage.
Autorzy:
Pawar SD; ICMR-National Institute of Virology, Microbial Containment Complex, 130/1, Sus Road, Pashan, Pune 411021, India. Electronic address: .
Tare DS; ICMR-National Institute of Virology, Microbial Containment Complex, 130/1, Sus Road, Pashan, Pune 411021, India.
Kode SS; ICMR-National Institute of Virology, Microbial Containment Complex, 130/1, Sus Road, Pashan, Pune 411021, India.
Keng SS; ICMR-National Institute of Virology, Microbial Containment Complex, 130/1, Sus Road, Pashan, Pune 411021, India.
Pokaż więcej
Źródło:
Journal of virological methods [J Virol Methods] 2023 Dec; Vol. 322, pp. 114830. Date of Electronic Publication: 2023 Oct 01.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Influenza A Virus, H5N1 Subtype*
Influenza Vaccines*
Animals ; Humans ; Glutaral ; Antibodies, Viral ; Influenza A Virus, H3N2 Subtype ; Hemagglutination Inhibition Tests ; Turkeys ; Erythrocytes
Czasopismo naukowe
Tytuł:
Elastomeric half-mask respirator disinfection practices among healthcare personnel.
Autorzy:
Hines SE; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Thurman P; University of Maryland Medical Center, Baltimore, Maryland, USA.
Zhuang E; University of Maryland Medical Center, Baltimore, Maryland, USA.
Chen H; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
McDiarmid M; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Chalikonda S; Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Angelilli S; Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Waltenbaugh H; Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Napoli M; Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Haas E; National Personal Protective Technology Laboratory, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Pittsburgh, Pennsylvania, USA.
McClain C; National Personal Protective Technology Laboratory, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Pittsburgh, Pennsylvania, USA.
Sietsema M; National Personal Protective Technology Laboratory, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Pittsburgh, Pennsylvania, USA.
Fernando R; National Personal Protective Technology Laboratory, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Pittsburgh, Pennsylvania, USA.
Pokaż więcej
Źródło:
American journal of industrial medicine [Am J Ind Med] 2023 Dec; Vol. 66 (12), pp. 1056-1068. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Respiratory Protective Devices*
COVID-19*/prevention & control
Humans ; Disinfection ; Ventilators, Mechanical ; Delivery of Health Care
Czasopismo naukowe
Tytuł:
Histomorphometric lung density evaluation of Immulina treatment using a murine influenza pneumonia model.
Autorzy:
Wilson FD; Mississippi Veterinary Research and Diagnostic Laboratory, Mississippi State University, Pearl, Mississippi, USA.
Mir TM; National Center for Natural Products Research, School of Pharmacy, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA.
Ashfaq MK; National Center for Natural Products Research, School of Pharmacy, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA.
Zhang J; National Center for Natural Products Research, School of Pharmacy, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA.
Pugh ND; National Center for Natural Products Research, School of Pharmacy, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA.
Khan IA; National Center for Natural Products Research, School of Pharmacy, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA.; Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, Mississippi, USA.
Pace LW; Mississippi Veterinary Research and Diagnostic Laboratory, Mississippi State University, Pearl, Mississippi, USA.
Hoerr FJ; Veterinary Diagnostic Pathology, Fort Valley, Virginia, USA.
Pokaż więcej
Źródło:
International journal of experimental pathology [Int J Exp Pathol] 2023 Dec; Vol. 104 (6), pp. 283-291. Date of Electronic Publication: 2023 Sep 26.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Pneumonia*/drug therapy
Animals ; Mice ; Humans ; Lung
Czasopismo naukowe
Tytuł:
The truncated IFITM3 facilitates the humoral immune response in inactivated influenza vaccine-vaccinated mice via interaction with CD81.
Autorzy:
Xie Q; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, People's Republic of China.; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China.
Liao X; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, People's Republic of China.; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China.
Huang B; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, People's Republic of China.; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China.
Wang L; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, People's Republic of China.; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China.
Liao G; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, People's Republic of China.; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China.
Luo C; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, People's Republic of China.; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China.
Wen S; Guangzhou First People's Hospital, the Second Affiliated Hospital of South China University of Technology, Guangzhou, People's Republic of China.
Fang S; Pathogenic Microorganism Testing Institute, Shenzhen Center for Disease Control and Prevention, Shenzhen, People's Republic of China.
Luo H; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, People's Republic of China.; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China.; Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, People's Republic of China.
Shu Y; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, People's Republic of China.; School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China.; Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (2), pp. 2246599.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*
Animals ; Mice ; Humans ; Immunity, Humoral ; Influenza A Virus, H3N2 Subtype/genetics ; Immunoglobulin G ; Amino Acids ; Antibodies, Viral
Czasopismo naukowe
Tytuł:
Cell-intrinsic genomic reassortment of pandemic H1N1 2009 and Eurasian avian-like swine influenza viruses results in potentially zoonotic variants.
Autorzy:
Ferrando VA; Institute of Virology Münster, Westfälische Wilhelms-University, Münster, Germany.
Friedrich ME; Institute of Virology Münster, Westfälische Wilhelms-University, Münster, Germany.
Gandhi S; Department of Genetic Epidemiology, Institute of Human Genetics, Westfälische Wilhelms-University, Münster, Germany.
Mellmann A; Institute of Hygiene Münster, Westfälische Wilhelms-University, Münster, Germany.
Masemann D; Institute of Virology Münster, Westfälische Wilhelms-University, Münster, Germany.
Christersson A; Institute of Virology Münster, Westfälische Wilhelms-University, Münster, Germany.
Anhlan D; Institute of Virology Münster, Westfälische Wilhelms-University, Münster, Germany.
Brunotte L; Institute of Virology Münster, Westfälische Wilhelms-University, Münster, Germany.
Stoll M; Department of Genetic Epidemiology, Institute of Human Genetics, Westfälische Wilhelms-University, Münster, Germany.
Harder T; Institute of Diagnostic Virology, Friedrich-Loeffler-Institute, Greifswald, Germany.
Beer M; Institute of Diagnostic Virology, Friedrich-Loeffler-Institute, Greifswald, Germany.
Boergeling Y; Institute of Virology Münster, Westfälische Wilhelms-University, Münster, Germany.
Ludwig S; Institute of Virology Münster, Westfälische Wilhelms-University, Münster, Germany.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2212809.
Typ publikacji:
Journal Article
MeSH Terms:
Orthomyxoviridae Infections*/epidemiology
Orthomyxoviridae Infections*/veterinary
Influenza A Virus, H1N1 Subtype*/genetics
Influenza A virus*/genetics
Swine Diseases*/epidemiology
Influenza, Human*/epidemiology
Animals ; Humans ; Swine ; Reassortant Viruses/genetics ; Genomics
Czasopismo naukowe
Tytuł:
Beyond COVID-19: the impact of recent pandemics on medical students and their education: a scoping review.
Autorzy:
Bughrara MS; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
Swanberg SM; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.; Moustakas Johnson Library, Michigan School of Psychology, Farmington Hills, MI, USA.
Lucia VC; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
Schmitz K; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
Jung D; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.; Department of Emergency Medicine, Oakland University William Beaumont School of Medicine Beaumont Health, Royal Oak, MI, USA.
Wunderlich-Barillas T; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
Pokaż więcej
Źródło:
Medical education online [Med Educ Online] 2023 Dec; Vol. 28 (1), pp. 2139657.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
COVID-19*/epidemiology
Influenza A Virus, H1N1 Subtype*
Students, Medical*
Zika Virus*
Zika Virus Infection*
Humans ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial.
Autorzy:
Leroux-Roels I; Center for Vaccinology, Ghent, Belgium.
Willems P; Osivax, Lyon, France.
Waerlop G; Center for Vaccinology, Ghent, Belgium.
Janssens Y; Center for Vaccinology, Ghent, Belgium.
Tourneur J; Osivax, Lyon, France.
De Boever F; Center for Vaccinology, Ghent, Belgium.
Bruhwyler J; Osivax, Lyon, France. Electronic address: .
Alhatemi A; Center for Vaccinology, Ghent, Belgium.
Jacobs B; Center for Vaccinology, Ghent, Belgium.
Nicolas F; Osivax, Lyon, France.
Leroux-Roels G; Center for Vaccinology, Ghent, Belgium.
Le Vert A; Osivax, Lyon, France.
Pokaż więcej
Źródło:
The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Dec; Vol. 23 (12), pp. 1360-1369. Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*/adverse effects
Influenza, Human*/prevention & control
Adult ; Humans ; Antibodies, Viral ; Double-Blind Method ; Immunogenicity, Vaccine ; Leukocytes, Mononuclear ; Vaccination ; Adolescent ; Young Adult ; Middle Aged
Czasopismo naukowe
Tytuł:
An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses.
Autorzy:
Xiong F; Shanghai Institute of Biological Products, Shanghai, People's Republic of China.
Zhang C; Shanghai Institute of Biological Products, Shanghai, People's Republic of China.
Shang B; Shanghai Institute of Biological Products, Shanghai, People's Republic of China.
Zheng M; Shanghai Institute of Biological Products, Shanghai, People's Republic of China.
Wang Q; Shanghai Institute of Biological Products, Shanghai, People's Republic of China.
Ding Y; Shanghai Institute of Biological Products, Shanghai, People's Republic of China.
Luo J; Shanghai Institute of Biological Products, Shanghai, People's Republic of China.
Li X; Shanghai Institute of Biological Products, Shanghai, People's Republic of China.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (2), pp. 2256422. Date of Electronic Publication: 2023 Sep 06.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*/genetics
Influenza A Virus, H9N2 Subtype*
Influenza A Virus, H1N1 Subtype*/genetics
Influenza, Human*/prevention & control
Humans ; Animals ; Mice ; CD8-Positive T-Lymphocytes ; Influenza A Virus, H3N2 Subtype/genetics
Czasopismo naukowe
Tytuł:
Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence.
Autorzy:
Ma N; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Xia ZW; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; School of Animal Science and Technology, School of Animal Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Zhang ZG; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Nian XX; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Li XD; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Gong Z; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Zhang GM; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Le Y; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Zhou R; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Zhang JY; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; The Second Laboratory of Viral Vaccine Research, Wuhan Institute of Biological Products Co. Ltd., Wuhan, People's Republic of China.
Yang XM; National Engineering Technology Research Center for Combined Vaccines, Wuhan, People's Republic of China.; China National Biotec Group Company Limited, Beijing, People's Republic of China.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2202278.
Typ publikacji:
Journal Article
MeSH Terms:
Orthomyxoviridae Infections*
Influenza A Virus, H1N1 Subtype*/genetics
Influenza, Human*
Influenza Vaccines*
Influenza A virus*
Humans ; Animals ; Mice ; Hemagglutinins ; Consensus ; Seasons ; Antibodies, Viral ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł:
The protective effect of 999 XiaoErGanMao granules on the lungs and intestines of influenza A virus-infected mice.
Autorzy:
Hao YZ; Department of Biological Medicines & Shanghai Engineering Research Center of ImmunoTherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Cen LF; Department of Biological Medicines & Shanghai Engineering Research Center of ImmunoTherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Wang T; Department of Biological Medicines & Shanghai Engineering Research Center of ImmunoTherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Yi T; Department of Biological Medicines & Shanghai Engineering Research Center of ImmunoTherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Shi XL; Department of Biological Medicines & Shanghai Engineering Research Center of ImmunoTherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Duan HJ; China Resources Sanjiu Medical & Pharmaceutical Co., Ltd, Shenzhen, China.
Dai Z; China Resources Sanjiu Medical & Pharmaceutical Co., Ltd, Shenzhen, China.
Zhu HY; Department of Biological Medicines & Shanghai Engineering Research Center of ImmunoTherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Tang JG; Department of Trauma-Emergency & Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Pharmaceutical biology [Pharm Biol] 2023 Dec; Vol. 61 (1), pp. 630-638.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A virus*/metabolism
Influenza A Virus, H1N1 Subtype*
Male ; Animals ; Mice ; Lung ; Cytokines/metabolism ; Intestines ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł:
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD.
Autorzy:
Li Y; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Liu P; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Hao T; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Liu S; Cryo-EM Center, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Wang X; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Xie Y; Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, People's Republic of China.
Xu K; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Lei W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Zhang C; Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, People's Republic of China.
Han P; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.
Li Y; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Jin X; School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
Huan Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Lu Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Zhang R; State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangxi University, Nanning, People's Republic of China.
Li X; Laboratory Animal Center, Chinese Center for Disease Control and Prevention (China CDC), Beijing, People's Republic of China.
Zhao X; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.
Xu K; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, People's Republic of China.
Liao P; Department of Clinical Laboratory, Chongqing General Hospital, Chongqing, People's Republic of China.
Lu X; Laboratory Animal Center, Chinese Center for Disease Control and Prevention (China CDC), Beijing, People's Republic of China.
Bi Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
Song H; University of Chinese Academy of Sciences, Beijing, People's Republic of China.; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, People's Republic of China.
Wu G; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Zhu B; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China.; Department of Pathogenic Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, People's Republic of China.
Gao GF; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, People's Republic of China.; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, People's Republic of China.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (2), pp. 2231573.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza A Virus, H1N1 Subtype*/genetics
COVID-19*/prevention & control
Influenza Vaccines*/genetics
Mice ; Animals ; Humans ; Hemagglutinins ; COVID-19 Vaccines ; Cryoelectron Microscopy ; Antibodies, Viral ; SARS-CoV-2 ; Antibodies, Neutralizing ; Spike Glycoprotein, Coronavirus/genetics
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses.
Autorzy:
Saksena NK; Victoria University, Footscray Campus, Melbourne, VIC. Australia. Electronic address: .
Reddy SB; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Miranda-Saksena M; Westmead Institute for Medical Research, Sydney. Australia. Electronic address: .
Cardoso THS; OMICS Centre of Excellence, G42 Healthcare, Mazdar City, Abu Dhabi, United Arab Emirates. Electronic address: .
Silva EMA; Science Division, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Ferreira JC; Science Division, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates. Electronic address: .
Rabeh WM; Science Division, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates. Electronic address: .
Pokaż więcej
Źródło:
Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2023 Dec; Vol. 1869 (8), pp. 166836. Date of Electronic Publication: 2023 Aug 05.
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/genetics
Influenza A Virus, H1N1 Subtype*
Zika Virus*
Zika Virus Infection*
Humans ; SARS-CoV-2/genetics ; Epigenomics
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Augmented antiviral activity of chlorhexidine gluconate on herpes simplex virus type 1, H1N1 influenza A virus, and adenovirus in combination with salicylic acid.
Autorzy:
Jamshidinia N; Pharmaceutical Biotechnology Lab, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, Tehran, 14155-6455, Iran.
Saadatpour F; Molecular Virology Lab, Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, 14155-6455, Iran.
Arefian E; Molecular Virology Lab, Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, 14155-6455, Iran. .
Mohammadipanah F; Pharmaceutical Biotechnology Lab, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, Tehran, 14155-6455, Iran. .
Pokaż więcej
Źródło:
Archives of virology [Arch Virol] 2023 Nov 30; Vol. 168 (12), pp. 302. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Herpesvirus 1, Human*
Influenza A Virus, H1N1 Subtype*
Adenoviridae Infections*
Anti-Infective Agents, Local*
Humans ; Adenoviridae/genetics ; Salicylic Acid/pharmacology ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus.
Autorzy:
Aikawa NE; Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, 3Rd Floor, room 3190 - Cerqueira Cesar, São Paulo, SP, CEP 05403-010, Brazil. .; Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. .
Borba EF; Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Balbi VA; Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, 3Rd Floor, room 3190 - Cerqueira Cesar, São Paulo, SP, CEP 05403-010, Brazil.
Sallum AME; Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, 3Rd Floor, room 3190 - Cerqueira Cesar, São Paulo, SP, CEP 05403-010, Brazil.
Buscatti IM; Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, 3Rd Floor, room 3190 - Cerqueira Cesar, São Paulo, SP, CEP 05403-010, Brazil.
Campos LMA; Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, 3Rd Floor, room 3190 - Cerqueira Cesar, São Paulo, SP, CEP 05403-010, Brazil.
Kozu KT; Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, 3Rd Floor, room 3190 - Cerqueira Cesar, São Paulo, SP, CEP 05403-010, Brazil.
Garcia CC; Laboratory of Respiratory, Exanthematic Viruses, Enterovirus and Viral Emergencies, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, RJ, Brazil.; Integrated Research Group On Biomarkers. René Rachou Institute, FIOCRUZ Minas, Belo Horizonte, MG, Brazil.
Capão ASV; Laboratory of Respiratory, Exanthematic Viruses, Enterovirus and Viral Emergencies, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, RJ, Brazil.
de Proença ACT; Department of Infectious and Parasitic Diseases, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Leon EP; Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
da Silva Duarte AJ; Clinical Laboratory Division - Department of Pathology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Lopes MH; Department of Infectious and Parasitic Diseases, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Silva CA; Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, 3Rd Floor, room 3190 - Cerqueira Cesar, São Paulo, SP, CEP 05403-010, Brazil.; Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Bonfá E; Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Pokaż więcej
Źródło:
Advances in rheumatology (London, England) [Adv Rheumatol] 2023 Nov 28; Vol. 63 (1), pp. 55. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*/adverse effects
Influenza, Human*/prevention & control
Influenza, Human*/epidemiology
Lupus Erythematosus, Systemic*/epidemiology
Female ; Humans ; Antibodies, Viral ; Influenza A Virus, H3N2 Subtype ; Male ; Child ; Adolescent
Czasopismo naukowe
Tytuł:
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine.
Autorzy:
Van Reeth K; Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Gent, Belgium. .
Parys A; Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Gent, Belgium.
Gracia JCM; Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Gent, Belgium.
Trus I; Dioscuri Centre for RNA-Protein Interactions in Human Health and Disease, International Institute of Molecular and Cell Biology, Warsaw, Poland.
Chiers K; Laboratory of Pathology, Faculty of Veterinary Medicine, Ghent University, Gent, Belgium.
Meade P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Liu S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Vandoorn E; Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Gent, Belgium.
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Nov 27; Vol. 14 (1), pp. 7745. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza A virus*
Influenza Vaccines*
Influenza, Human*
Orthomyxoviridae Infections*
Humans ; Animals ; Swine ; Antibodies, Neutralizing ; Antibodies, Viral ; Vaccination
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies